Substrate-dependent oligomerization modulates DGAT1 activity and subcellular localization

This study reveals that the substrate diacylglycerol (DAG) promotes DGAT1 oligomerization and drives its localization to curved ER tubules, thereby modulating the enzyme's activity and subcellular distribution during triglyceride synthesis.

The Gist

The Big Picture: The Cell's Warehouse and the Factory Manager

Imagine your cell is a bustling city. Inside this city, there is a massive warehouse called the Lipid Droplet (LD). This warehouse stores energy in the form of fat (triglycerides), which the cell can use later when it's hungry.

To fill this warehouse, the cell needs a factory manager. That manager is an enzyme called DGAT1. Its job is to take two raw ingredients—Acyl-CoA (a fatty acid delivery truck) and DAG (a building block)—and snap them together to create the final product: Triglycerides (the fat stored in the warehouse).

For a long time, scientists knew DGAT1 existed, but they didn't know exactly how it worked, where it stood in the factory, or how it knew when to start building. This paper acts like a high-tech detective story, using computer simulations and real-life experiments to solve the mystery.

Here are the four main discoveries, explained simply:

---

1. The Secret Back Door (How the Ingredients Enter)

The Discovery: Scientists found that the building block (DAG) doesn't just walk in the front door. It sneaks in through a specific "side tunnel" on the inside of the cell membrane.

The Analogy: Imagine DGAT1 is a castle with a drawbridge. You might expect the delivery trucks to come from the outside (the cytoplasm). But this study found that the DAG trucks actually prefer a secret, hidden tunnel on the inside of the castle wall (the luminal leaflet).

• Why it matters: The castle has a special guard (a group of amino acids) at the entrance of this tunnel. If you break the guard's lock (by mutating the protein), the trucks can't get in, and the factory stops working. This explains exactly how the enzyme grabs its raw materials.

2. The Waiting Room is a Crowd (Multiple Ingredients at Once)

The Discovery: The study showed that DGAT1 doesn't just hold one DAG molecule at a time. Its internal "waiting room" is actually huge and can hold up to five DAG molecules simultaneously.

The Analogy: Think of DGAT1 not as a single-person booth, but as a busy coffee shop counter. Even if only one customer is being served, the counter is crowded with five people waiting with their orders.

• Why it matters: This means the factory is always stocked and ready to go. Even if the supply line is a bit slow, the enzyme has a buffer of ingredients right there, ready to be snapped together instantly.

3. The Curved Slide (Where the Factory Lives)

The Discovery: DGAT1 has a weird shape—it's cone-shaped. Because of this, it doesn't like flat surfaces. It loves to hang out in curved parts of the cell membrane, specifically the thin, tube-like structures of the Endoplasmic Reticulum (ER).

The Analogy: Imagine DGAT1 is a surfer. It hates flat, calm water (flat membranes). It only wants to surf on the steep, curved waves (the ER tubules).

• The Twist: The building block, DAG, is shaped like a cone too. It also loves to hang out on these steep, curved waves.
• The Result: Because both the Manager (DGAT1) and the Building Block (DAG) love the same "surfing spot," they naturally find each other there. This is where the factory is most efficient.

4. The Group Hug (Oligomerization)

The Discovery: When there is a lot of DAG around, the DGAT1 managers don't just work alone; they huddle together in groups (dimers, tetramers, and larger clusters).

The Analogy: Imagine the factory managers are individual workers. But when the raw material (DAG) starts pouring in, they realize, "Hey, we need to work as a team!" They grab hands and form a giant, super-efficient construction crew.

• The Feedback Loop: This is the most exciting part.
  1. DAG accumulates in the curved tubes.
  2. DGAT1 moves to the tubes to find the DAG.
  3. The presence of DAG makes the DGAT1 managers huddle together into big teams.
  4. These big teams are even better at sticking to the curved tubes.
  5. This creates a positive feedback loop: More DAG $\rightarrow$ More DGAT1 teams $\rightarrow$ Even more fat production right where the new warehouse (Lipid Droplet) is being built.

The Takeaway

This paper reveals that the cell is incredibly smart. It doesn't just randomly mix ingredients. Instead, it uses the shape of the ingredients and the shape of the machinery to organize everything.

• The Shape: The cone shape of the ingredients and the enzyme forces them to gather in the curved tubes of the cell.
• The Crowd: The ingredients encourage the enzymes to form teams.
• The Result: Fat storage happens exactly where it needs to, efficiently and quickly, ensuring the cell has energy when it needs it.

In short: DGAT1 is a shape-shifting, team-building factory manager that loves curved roads, and it uses its favorite ingredient (DAG) to build a super-efficient assembly line right where the new storage warehouses are being constructed.

Technical Summary

1. Problem Statement

Lipid Droplets (LDs) are essential organelles for energy storage, formed via the synthesis of triglycerides (TGs) in the Endoplasmic Reticulum (ER). The enzyme Diacylglycerol O-acyltransferase 1 (DGAT1) catalyzes the final step of TG synthesis by transferring an acyl group from acyl-CoA to diacylglycerol (DAG). While the cryo-EM structure of the human DGAT1 dimer has recently been solved, critical gaps remain in understanding:

• The precise molecular mechanism of substrate (DAG) entry and exit.
• The oligomerization state of DGAT1 in a native membrane environment.
• How DGAT1 activity, oligomerization, and subcellular localization are coordinated with membrane biophysics (specifically curvature) to facilitate LD biogenesis.

2. Methodology

The authors employed a multi-scale approach combining computational simulations with in vitro biochemical assays and in vivo live-cell imaging:

• All-Atom (AA) Molecular Dynamics (MD) Simulations:
  • Used the human DGAT1 dimer cryo-EM structure (complexed with oleoyl-CoA) embedded in an explicit DOPC:DAG lipid bilayer.
  • Ran 4 replicates of 3 µs each to observe spontaneous substrate recruitment and protein-membrane interactions.
  • Analyzed DAG entry pathways, residue contacts, and membrane curvature induction.
• Coarse-Grained (CG) MD Simulations:
  • Utilized the MARTINI3 forcefield to simulate DGAT1 in buckled (curved) bilayers.
  • Investigated DGAT1 preference for curved vs. flat membranes and the effect of DAG concentration on DGAT1 oligomerization (dimer vs. tetramer/higher-order).
• Biochemical Reconstitution & Crosslinking:
  • Activity Assays: Used yeast microsomes overexpressing wild-type and mutant DGAT1 to test enzymatic activity after mutating conserved residues identified in simulations.
  • Endogenous Substrate Binding: Purified human DGAT1 (without exogenous DAG) and tested TG formation using radiolabeled [14C]-oleoyl-CoA to prove the presence of co-purified DAG.
  • Chemical Crosslinking: Treated purified DGAT1 with Disuccinimidyl suberate (DSS) in the presence of DAG or oleoyl-CoA, followed by SDS-PAGE and Western Blotting to visualize oligomerization states.
• Live-Cell Microscopy:
  • Transfected human SUM159 breast cancer cells with EGFP-DGAT1 and an ER-luminal marker (BFP-KDEL).
  • Used Airyscan confocal microscopy and image segmentation (ilastik/CellProfiler) to quantify DGAT1 enrichment in ER sheets vs. ER tubules under baseline conditions, oleic acid stimulation, and DGAT inhibition (to induce DAG accumulation).

3. Key Contributions & Results

A. Mechanism of DAG Entry

• Pathway: AA-MD simulations revealed that DAG preferentially enters the DGAT1 catalytic pocket from the luminal leaflet of the ER membrane, contrary to previous hypotheses suggesting cytosolic entry.
• Residue Interaction: Entry involves a defined pathway interacting with conserved hydrophobic residues (Y111, L114, V115, W131) located on an amphipathic $\alpha$-helix at the cavity base.
• Validation: Mutating these residues to alanine reduced enzymatic activity by ~50%, confirming their critical role in substrate recruitment.

B. Multi-Ligand Binding Pocket

• Capacity: The catalytic pocket can simultaneously harbor multiple DAG molecules (up to five), not just one.
• Evidence: Purified DGAT1, when incubated with only [14C]-oleoyl-CoA (no exogenous DAG), successfully synthesized TG. This production was blocked by a DGAT inhibitor, proving that endogenous DAG co-purified with the enzyme and was sufficient for catalysis.

C. Membrane Curvature Sensing and Generation

• Asymmetry: DGAT1 dimers exhibit an asymmetric shape, shifted toward the cytosolic leaflet, inducing local membrane distortion.
• Curvature Preference: CG-MD simulations showed DGAT1 preferentially localizes to positively curved regions (radius ~37–40 nm), mimicking ER tubules.
• Feedback Loop: DAG, being a conical lipid, also accumulates in these curved regions. This creates a positive feedback loop where curved membranes enrich both the enzyme and its substrate.

D. Substrate-Dependent Oligomerization

• DAG-Induced Oligomerization: CG-MD simulations showed that high DAG concentrations promote the clustering of DGAT1 dimers into high-order oligomers (tetramers and beyond) specifically at curved membrane sites.
• Experimental Confirmation: DSS crosslinking assays demonstrated that while DGAT1 exists primarily as a dimer, the addition of DAG (but not oleoyl-CoA) induces the formation of trimers, tetramers, and higher oligomers.
• Curvature Amplification: Simulations indicated that DGAT1 tetramers have an even stronger preference for highly curved membranes than dimers, suggesting oligomerization reinforces localization to ER tubules.

E. Subcellular Localization in Live Cells

• Baseline: DGAT1 shows a slight enrichment in ER tubules compared to sheets.
• Stimulation: Treatment with oleic acid (to stimulate LD biogenesis) or DGAT inhibitors (causing DAG accumulation) significantly increases DGAT1 enrichment in ER tubules. This confirms that elevated DAG levels drive DGAT1 to the specific subcellular sites where LDs form.

4. Significance

This study provides a comprehensive molecular model for TG synthesis and LD biogenesis:

1. Mechanistic Insight: It resolves the "black box" of how DAG enters DGAT1, identifying a luminal entry pathway and a multi-ligand binding pocket.
2. Regulatory Mechanism: It establishes that DAG is not merely a substrate but a regulator of DGAT1. High DAG levels trigger oligomerization, which in turn enhances the enzyme's affinity for curved ER membranes.
3. Spatial Organization: The findings suggest a self-reinforcing cycle: DAG accumulation in ER tubules recruits DGAT1, promotes its oligomerization, and further concentrates the enzyme at these sites to maximize TG synthesis and LD budding.
4. Therapeutic Implications: Understanding how substrate availability modulates enzyme oligomerization and localization offers new targets for drug design against metabolic diseases, cancer, and viral infections where LD metabolism is dysregulated.

In summary, the paper demonstrates that the interplay between protein oligomerization, substrate biophysics, and membrane curvature creates a highly efficient, localized system for lipid storage within the cell.